Mahesheema Ali, PHD
Pathology
Mahesheema Ali, PHD
Pathology
About Me
I lead the Clinical Chemistry and Toxicology section at MetroHealth. I also serve as the CLIA Director for our rapid response labs in Brecksville, Cleveland Heights, and Parma, and I oversee our Point-of-Care Testing program across the system. My role is all about making sure our lab services are accurate, efficient, and patient-centered—because behind every test result is a person who deserves the best care.
I completed my Clinical Chemistry fellowship at Baylor College of Medicine and Texas Children’s Hospital, and I’m board-certified by the American Board of Clinical Chemistry. I also hold an academic appointment as Associate Professor of Laboratory Medicine at Case Western Reserve University School of Medicine, where I help train the next generation of laboratory professionals.
Whether I’m working behind the scenes in the lab or mentoring future scientists, my goal is to ensure that every patient benefits from high-quality, reliable diagnostics that support their health and healing.
Dr. Ali's professional interests include the advancement of in vitro diagnostic testing through the development, validation, and implementation of innovative laboratory methods. Her areas of expertise span automated chemistry, toxicology, mass spectrometry, and POCT. Dr. Ali is dedicated to promoting excellence and continuous improvement in clinical laboratory medicine.
1. International Standardization Forum at the AACC /Lipids Lipoprotein and Vascular Disease division, Outstanding Abstract Award
Date: July 2013
2. Society of Young Clinical Chemist and Laboratorians Award
Date: July 2015
3. AACC Texas Section, Best Oral Presentation Award
Date: October 2016
4.Baylor College of Medicine, Research Day Outstanding Abstract Award
Date: July 2017
5. Baylor College of Medicine Women of Excellence Award
Date: July 2018
6. The MetroHealth Medical System Medical Staff Excellence Award
Date: July 2022
PubMed Publications
- Diagnostic discrepancies: A retrospective analysis of two antinuclear antibody platforms Abstract: To retrospectively examine the outcome of the antinuclear antibody (ANA) screen by comparing the performance of BioPlex 2200 and immunofluorescence assay (IFA). We reviewed the ANA screening results performed on the BioPlex 2200 using multi-bead technology and the IFA using HEp-2 cells. The study encompassed 133 patients, comprising 111 females and 22 males. The average age of lupus patients at the time of diagnosis was approximately 53 years. Among 133 cases tested, 58 were negative, and 75...
- Human Chorionic Gonadotropin (hCG) Injections Exacerbating Acute Intermittent Porphyria in a 34-Year-Old Woman Abstract: A 34-year-old Asian woman arrived at the emergency department (ED) with complaints of sharp, cramping abdominal pain followed by stabbing chest pain that radiated to her back. She also reported numbness, tingling in both hands and feet, and a burning sensation. Upon examination, she exhibited tachycardia and persistently elevated blood pressure. Her lab results revealed low potassium and sodium levels. Despite testing negative for pregnancy, normal hepatic function test, and nerve conduction...
- Evaluation of a multiplex liquid chromatography-tandem mass spectrometry method for congenital adrenal hyperplasia in pediatric patients Abstract: Multiplexed adrenal steroid measurement provides critical diagnostic information for patients with congenital adrenal hyperplasia (CAH) as confirmation of newborn screening (NBS) or as initial diagnosis. This study reports the implementation of an adrenal steroid profiling method with a turnaround time (TAT) of less than 24 h using liquid chromatography and tandem-mass spectrometry (LC-MS/MS). A lab-developed multiplexed LC-MS/MS assay was used to quantify levels of 11-deoxycortisol, cortisol,...
- False positive urine amphetamine immunoassay due to solriamfetol Abstract: Solriamfetol is a schedule IV-controlled substance used to treat excessive daytime sleepiness resulting from narcolepsy or obstructive sleep apnea. We present a patient prescribed solriamfetol who tested positive for amphetamines on a routine urinary toxicology screen despite patient denial of illicit drug use, raising the possibility of a false positive amphetamine screen. Spiking studies were performed on negative urine, and different concentrations of solriamfetol drug on 2 different...
- AACC Guidance Document on the Use of Point-of-Care Testing in Fertility and Reproduction Abstract: CONCLUSIONS: This revision of the AACC Academy POCT guidelines provides recommendations for best practice use of POCT in fertility and reproduction.
- <em>Technical Note:</em> Glycolic Acid Exacerbates the Analytical Performance of Lactate Assay Abstract: In this study, we evaluated the analytical interference of glycolic acid on several lactate assays that use lactate oxidase and dehydrogenase. Herein, we tested the effect of different concentrations of glycolic acid (0.01-46mM) on the lactate assay by using central lab and point of care (POCT) analyzers: Radiometer ABL 800, Beckman AU480, Roche Cobas c502, and Abbott i-STAT. Glycolic acid concentrations as low as 0.12mM resulted in a ≥20% positive bias in lactate assay on the ABL 800 and a...
- Adolescent Female with Jaundice and Edema Abstract: No abstract
- Accuracy of Two Progesterone Immunoassays for Monitoring In Vitro Fertilization Abstract: CONCLUSIONS: The Abbott Architect progesterone immunoassay provides a more accurate measurement of serum progesterone than the Centaur immunoassay at concentrations relevant for monitoring in vitro fertilization populations.
- Validation of an Automated Assay for Levetiracetam (Keppra) on Vitros 5600 Abstract: CONCLUSIONS: The ARK Levetiracetam Assay on Ortho Clinical Diagnostic Vitros 5600 can be used for routine determination of levetiracetam for conducting therapeutic drug monitoring and optimizing individual dosage regimen.
- Utilization of Laboratory Testing Algorithms for Celiac Disease in a Pediatric Hospital Abstract: CONCLUSIONS: We were able to induce appropriate celiac test usage by implementing a celiac-reflexive cascade. Also, our strategy proved to be extremely cost effective.
- Revisiting sweat chloride test results based on recent guidelines for diagnosis of cystic fibrosis Abstract: CONCLUSION: Our findings concur with the new CF diagnosis guidelines that changing the intermediate cut-off to 30-59 mmol/L sweat chloride concentration in combination with CFTR genetic analysis enhances the probability of identifying individuals that have risk of developing CF or have CF and enables for earlier therapeutic intervention.
- Discordant Analytical Results Caused by Biotin Interference on Diagnostic Immunoassays in a Pediatric Hospital Abstract: Recent studies have reported that biotin interferes with certain immunoassays. In this study, we evaluated the analytical interference of biotin on immunoassays that use streptavidin-biotin in our pediatric hospital. We tested the effect of different concentrations of biotin (1.5-200 ng/ml) on TSH, Prolactin, Ferritin, CK-MB, β-hCG, Troponin I, LH, FSH, Cortisol, Anti-HAV antibody (IgG and IgM), assays on Ortho Clinical Diagnostic Vitros 5600 Analyzer. Biotin (up to 200 ng/mL) did not...
Education & Training
Education
Graduate School
Cleveland State University (Ohio) Ph.DFellowship
Baylor College of Medicine – Bioanalytical & Clinical Chemistry